Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease

NIA-LOAD family study group, NCRAD

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Alzheimer disease (AD), Frontotemporal lobar degeneration (FTD), Amyotrophic lateral sclerosis (ALS) and Parkinson disease (PD) have a certain degree of clinical, pathological and molecular overlap. Previous studies indicate that causative mutations in AD and FTD/ALS genes can be found in clinical familial AD. We examined the presence of causative and low frequency coding variants in the AD, FTD, ALS and PD Mendelian genes, in over 450 families with clinical history of AD and over 11,710 sporadic cases and cognitive normal participants from North America. Known pathogenic mutations were found in 1.05% of the sporadic cases, in 0.69% of the cognitively normal participants and in 4.22% of the families. A trend towards enrichment, albeit non-significant, was observed for most AD, FTD and PD genes. Only PSEN1 and PINK1 showed consistent association with AD cases when we used ExAC as the control population. These results suggest that current study designs may contain heterogeneity and contamination of the control population, and that current statistical methods for the discovery of novel genes with real pathogenic variants in complex late onset diseases may be inadequate or underpowered to identify genes carrying pathogenic mutations.

Original languageEnglish
Article numbere1007045
JournalPLoS genetics
Volume13
Issue number11
DOIs
StatePublished - Nov 2017

Fingerprint Dive into the research topics of 'Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease'. Together they form a unique fingerprint.

  • Cite this